Carboplatin injection
Products billed under this code include Carboplatin.
Payment limit per 50 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Carboplatin.
Payment limit per 50 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Carboplatin | Teva Parenteral Medicines, Inc. | 00703-4239-01 | 12 | $37.212 |
| Carboplatin | Teva Parenteral Medicines, Inc. | 00703-4239-81 | 12 | $37.212 |
| Carboplatin | Teva Parenteral Medicines, Inc. | 00703-4244-01 | 1 | $3.101 |
| Carboplatin | Teva Parenteral Medicines, Inc. | 00703-4244-81 | 1 | $3.101 |
| Carboplatin | Teva Parenteral Medicines, Inc. | 00703-4246-01 | 3 | $9.303 |
| Carboplatin | Teva Parenteral Medicines, Inc. | 00703-4246-81 | 3 | $9.303 |
| Carboplatin | Teva Parenteral Medicines, Inc. | 00703-4248-01 | 9 | $27.909 |
| Carboplatin | Teva Parenteral Medicines, Inc. | 00703-4248-81 | 9 | $27.909 |
| Carboplatin | Accord Healthcare Inc | 16729-0295-12 | 12 | $37.212 |
| Carboplatin | Accord Healthcare Inc | 16729-0295-34 | 9 | $27.909 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Carboplatin | Eugia US LLC | 55150-0335-00 | 9 | $27.909 |
| Carboplatin | Eugia US LLC | 55150-0335-01 | 9 | $27.909 |
| Carboplatin | Eugia US LLC | 55150-0386-00 | 12 | $37.212 |
| Carboplatin | Eugia US LLC | 55150-0386-01 | 12 | $37.212 |
| Carboplatin | Apotex Corp | 60505-6282-01 | 1 | $3.101 |
| Carboplatin | Apotex Corp | 60505-6282-03 | 3 | $9.303 |
| Carboplatin | Apotex Corp | 60505-6282-06 | 9 | $27.909 |
| Carboplatin | Apotex Corp | 60505-6282-07 | 12 | $37.212 |
| Carboplatin | Pfizer Inc | 61703-0150-05 | 3 | $9.303 |
| Carboplatin | Pfizer Inc | 61703-0262-05 | 9 | $27.909 |
| Carboplatin | Pfizer Inc | 61703-0339-18 | 1 | $3.101 |
| Carboplatin | Pfizer Inc | 61703-0339-22 | 3 | $9.303 |
| Carboplatin | Pfizer Inc | 61703-0339-50 | 9 | $27.909 |
| Carboplatin | Pfizer Inc | 61703-0339-56 | 12 | $37.212 |
| Carboplatin | Pfizer Inc | 61703-0360-18 | 1 | $3.101 |
| Carboplatin | Pfizer Inc | 61703-0600-05 | 12 | $37.212 |
| Carboplatin | FreseniUS Kabi USA, LLC | 63323-0172-60 | 12 | $37.212 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $3.101 | −$0.052 | 50 MG | Carboplatin injection | v1, posted September 17, 2026 |
| 3Q26 | $3.153 | +$0.216 | 50 MG | Carboplatin injection | v1, posted September 15, 2026 |
| 2Q26 | $2.937 | +$0.008 | 50 MG | Carboplatin injection | v1, posted September 15, 2026 |
| 1Q26 | $2.929 | +$0.458 | 50 MG | Carboplatin injection | v1, posted September 15, 2026 |
| 4Q25 | $2.471 | +$0.36 | 50 MG | Carboplatin injection | v1, posted September 8, 2026 |
| 3Q25 | $2.111 | −$0.819 | 50 MG | Carboplatin injection | v1, posted March 10, 2026 |
| 2Q25 | $2.93 | −$0.70 | 50 MG | Carboplatin injection | v1, posted March 10, 2026 |
| 1Q25 | $3.63 | +$0.23 | 50 MG | Carboplatin injection | v1, posted December 19, 2025 |
| 4Q24 | $3.40 | −$0.291 | 50 MG | Carboplatin injection | v1, posted June 11, 2025 |
| 3Q24 | $3.691 | −$0.031 | 50 MG | Carboplatin injection | v1, posted June 11, 2025 |
| 2Q24 | $3.722 | +$0.123 | 50 MG | Carboplatin injection | v1, posted March 11, 2025 |
| 1Q24 | $3.599 | +$0.841 | 50 MG | Carboplatin injection | v1, posted December 19, 2024 |
| 4Q23 | $2.758 | +$0.35 | 50 MG | Carboplatin injection | v1, posted October 10, 2024 |
| 3Q23 | $2.408 | +$0.038 | 50 MG | Carboplatin injection | v1, posted June 5, 2024 |
| 2Q23 | $2.37 | −$0.113 | 50 MG | Carboplatin injection | v1, posted February 23, 2024 |
| 1Q23 | $2.483 | −$0.184 | 50 MG | Carboplatin injection | v1, posted December 6, 2023 |
| 4Q22 | $2.667 | −$0.255 | 50 MG | Carboplatin injection | v1, posted June 22, 2023 |
| 3Q22 | $2.922 | +$0.154 | 50 MG | Carboplatin injection | v1, posted June 9, 2023 |
| 2Q22 | $2.768 | +$0.16 | 50 MG | Carboplatin injection | v1, posted December 14, 2022 |
| 1Q22 | $2.608 | −$0.035 | 50 MG | Carboplatin injection | v1, posted June 8, 2022 |
| 4Q21 | $2.643 | +$0.164 | 50 MG | Carboplatin injection | v1, posted June 2, 2022 |
| 3Q21 | $2.479 | −$0.085 | 50 MG | Carboplatin injection | v1, posted June 2, 2022 |
| 2Q21 | $2.564 | −$0.116 | 50 MG | Carboplatin injection | v1, posted March 1, 2022 |
| 1Q21 | $2.68 | – | 50 MG | Carboplatin injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.